For multi-arm studies or extended longitudinal work where between-condition consistency is a controlled variable, drawing from a single sealed 40mg supply is the cleaner experimental design
Triple-Hormone-Receptor Agonist GLP-3 R for Obesity - A Phase 2 Trial
Several licensed weight management injectable therapies are available in the UK including semaglutide (Wegovy, approved by NICE for weight management in eligible adults) and tirzepatide (Mounjaro, licensed in the UK for type 2 diabetes and, subject to current NICE guidance, for weight management in eligible adults)
The encouraging news is that in most cases, its temporary and reversible
5 Lower doses: Eight in ten real-world patients were on maintenance doses below 1.7 mg of semaglutide or 10 mg of tirzepatide
Adding it to a Retatrutide protocol means you are addressing visceral fat from two directions: the overall caloric deficit driving general fat loss, plus a direct, targeted assault on the deep abdominal stores